The Traderszone Network

Shares of Cerence (NASDAQ: CRNC) were plummeting almost 18.8% as of 11:58 a.m. ET Monday after the auto-focused software company reported fiscal fourth-quarter earnings that offered guidance that was below Wall Street’s expectations. 

Although Cerence beat analysts’ top- and bottom-line forecasts, its outlook for the coming fiscal first quarter was well below the mark. The software specialist guided for a range of $91 million to $96 million, short of the $101.3 million Wall Street anticipated.

Image source: Getty Images.

read more

Tesla Owners Left Stranded In Cold After Smartphone App Crashes Over Weekend

It’s the most wonderful time of the year…that is, unless you are a Tesla owner stranded in the freezing cold unable to get inside your vehicle.

Tesla owners got a nice early holiday gift this weekend when several owners reported not being able to get into their car due to “500 server errors” popping up on their Tesla smartphone apps.

read more

Intensive care units and morgues are filling up in Romania amid record levels of Covid-19 related deaths and one of Europe’s lowest vaccination rates. Doctors say they can’t see the light at the end of the tunnel, as vast swathes of the population remain reluctant to get vaccinated. Medics say they struggle against fake news, suspicion and superstition. CNN’s Ben Wedeman reports from Romania.

Keskisuomalainen Oyj, pörssitiedote, 22.11.2021 klo 14.30

Keskisuomalainen Oyj on tänään 22.11.2021 sopinut marraskuussa 2022 erääntyvän rahoituksensa uudelleenjärjestelystä. Yhtiö on solminut 60 miljoonan euron suuruisen rahoitussopimuksen Nordea Bank Oyj:n kanssa. Järjestelyllä muutetaan ja uudistetaan aiemmin voimassa ollut rahoitussopimus. Uusi laina erääntyy marraskuussa 2026.

Sopimus sisältää taloudellisia kovenantteja, jotka perustuvat Keskisuomalainen Oyj:n nettovelan ja käyttökatteen suhteeseen sekä omavaraisuusasteeseen.

read more

BOSTON, Nov. 22, 2021 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced that Regeneron has extended the research term of its collaboration with the Company to discover and develop gene therapies for hearing loss. The research term will be extended to November 15, 2023, and Regeneron will pay Decibel an extension fee of $10 million in Q4 of 2022.

Acquisition strengthens Outbrain’s video offering for media owners and advertisers;

MIAMI, Nov. 22, 2021 (GLOBE NEWSWIRE) — Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“Ayr” or the “Company”), a vertically-integrated cannabis multi-state operator (MSO), is reporting financial results for the three and nine months ended September 30, 2021. Unless otherwise noted, all results are presented in U.S. dollars.